TG United Recalls NoHist Tablets Due to Underdosing
TG United, Inc. is recalling NoHist Tablets because they are underdosed or have an incorrect dosage regime.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The specific hazard is underdosing, which is a quality deviation rather than a high-risk pathogen or structural defect, fitting the Moderate criteria for low-risk contamination or labeling/dosage errors without reported serious injury.
Plain-English summary
TG United, Inc. is recalling NoHist Tablets, an over-the-counter antihistamine and nasal decongestant product. The recall involves 4,824 bottles of the 100-count variety, identified by Lot# 11K010 and an expiration date of 09/13. The product was distributed by Larken Laboratories, Inc., in Canton, MS, and was available in Florida, Mississippi, South Carolina, Louisiana, and Texas.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the products are underdosed or have an incorrect dosage regime. This classification is designated as FDA Class II.
Consumers who have purchased this specific lot of NoHist Tablets should stop using the product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- NoHist TABLETS, Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Distributed by: Larken Laboratories, Inc., Canton, MS 39046, NDC 68047-173-01
- Manufacturer
- TG United, Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot# 11K010 Exp. 09/13.
Distribution
Part of a larger recall action
This product is one of 44 recalled by TG United, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 44 products in this recall →Related recalls
Same manufacturer · TG United, Inc.
See all →- SevereTG United Recalls Trigofen DM Drops Due to Underdosing
FDA (Drugs) · 2013-06-12
- SevereTG United Recalls Underdosed AMBI Antihistamine Nasal Decongestant Syrup
FDA (Drugs) · 2013-06-12
- ModerateTG United Recalls Underdosed AMBI Cough Suppressant and Expectorant
FDA (Drugs) · 2013-06-12
- SevereTG United Recalls Z-Dex Syrup Due to Underdosing and Incorrect Dosage
FDA (Drugs) · 2013-06-12
- ModerateTG United Recalls CPM PSE Drops Due to CGMP Deviations
FDA (Drugs) · 2013-06-12
Same hazard · underdosing
See all →- SevereBD Texium Closed System Drug Transfer Devices May Leak at Connector
FDA (Devices) · 2025-06-18
- HighBD TEXIUM Closed Male Luer Devices Recalled for Leaking Interface Risk
FDA (Devices) · 2025-06-18
- HighAlaris Pump Infusion Sets may leak at male luer connections
FDA (Devices) · 2025-06-18
- HighBD TEXIUM Closed Male Luer Drug Transfer Device Recall
FDA (Devices) · 2025-06-18
- HighBD Texium Needle-Free Syringe Recalled for Potential Leakage at Luer Interface
FDA (Devices) · 2025-06-18
Similar recalls
- ModerateWockhardt Recalls Famotodine Tablets Due to Complaint Investigation Failures
FDA (Drugs) · 2015-07-29
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08
- ModerateWockhardt Recalls Famotodine Tablets Due to CGMP Deviations
FDA (Drugs) · 2015-07-29
- ModerateAntihistamine and Decongestant Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2021-12-15
- ModerateSinus Decongestant Nasal Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateCardinal Health Recalls NOHIST DM Due to Temperature Excursions
FDA (Drugs) · 2021-06-02